In their 1/28/2023 article: Weak immune system? Government offers advice to help at-risk people avoid COVID-19 infections in the wake of the FDA’s withdrawal of Evusheld’s emergency authorization as it was ineffective for over 90% of the active SARS-CoV-2 variants of concerns, USA Today urges the immunocompromised to have a plan in place and links to CLL Society’s COVID-19 Action Plan as a helpful resource.
CLL Society is proud of the expanded role it is playing in helping not just the CLL / SLL community but all those who are vulnerable because they are immunocompromised or immune suppressed due to medications.
